GLUTATHIONE-S-TRANSFERASE M1 AND T1 POLYMORPHISMS - SUSCEPTIBILITY TO COLON-CANCER AND AGE-OF-ONSET

被引:177
作者
CHENEVIXTRENCH, G
YOUNG, J
COGGAN, M
BOARD, P
机构
[1] BANCROFT CTR,CLIN RES CTR,GLAXO LAB,BRISBANE,QLD,AUSTRALIA
[2] AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,MOLEC GENET GRP,CANBERRA,ACT 2601,AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.1093/carcin/16.7.1655
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
M1 member of the Mu subclass of glutathione S-transferase (GSTM1) is only expressed in about 50% of individuals. In contrast, GSTT1, a member of the theta class which has been recently shown to be polymorphic, is expressed in 85% of Australian individuals. Previous studies have shown a significant excess of homozygous null GSTM1 genotypes among individuals with colorectal cancer, particularly those with proximal tumours. This suggests that GSTM1 plays a role in susceptibility to this neoplasm. In this study of 132 individuals with colorectal cancer and 200 controls, no significant excess of GSTM1 homozygous null genotypes was found among colorectal cancer patients with either a proximal or distal tumour. This suggests that the association between GSTM1 homozygous null genotypes and colorectal cancer is of smaller effect than has been reported previously using larger sample sizes. We have also examined the frequency of homozygous null GSTT1 genotypes in patients with colorectal cancer. Although the frequency was not significantly different in cases compared to control individuals, GSTT1 null homozygotes were significantly more common in patients who where diagnosed before the age of 70 years than in those who were diagnosed at an older age. This suggests that the GSTT1 genotype, and perhaps also the GSTM1 genotype for which a similar, but non-significant effect was seen, might influence the age of onset of colorectal cancer.
引用
收藏
页码:1655 / 1657
页数:3
相关论文
共 22 条
[1]  
BOARD P, 1992, BLOOD, V80, P937
[2]   GENETIC-HETEROGENEITY OF THE HUMAN GLUTATHIONE TRANSFERASES - A COMPLEX OF GENE FAMILIES [J].
BOARD, P ;
COGGAN, M ;
JOHNSTON, P ;
ROSS, V ;
SUZUKI, T ;
WEBB, G .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :357-369
[3]  
BOARD PG, 1981, AM J HUM GENET, V33, P36
[5]  
BROCKMOLLER J, 1993, CANCER RES, V53, P1004
[6]   RESTRICTION FRAGMENT LENGTH POLYMORPHISMS OF L-MYC AND MYB IN HUMAN-LEUKEMIA AND LYMPHOMA IN RELATION TO AGE-SELECTED CONTROLS [J].
CHENEVIXTRENCH, G ;
SOUTHALL, M ;
KIDSON, C .
BRITISH JOURNAL OF CANCER, 1989, 60 (06) :872-874
[7]   GST1 GENE DELETION DETERMINED BY POLYMERASE CHAIN-REACTION [J].
COMSTOCK, KE ;
SANDERSON, BJS ;
CLAFLIN, G ;
HENNER, WD .
NUCLEIC ACIDS RESEARCH, 1990, 18 (12) :3670-3670
[8]   GLUTATHIONE-S-TRANSFERASE GSTM1 PHENOTYPES AND PROTECTION AGAINST CUTANEOUS TUMORS [J].
HEAGERTY, AHM ;
FITZGERALD, D ;
SMITH, A ;
BOWERS, B ;
JONES, P ;
FRYER, AA ;
ZHAO, L ;
ALLDERSEA, J ;
STRANGE, RC .
LANCET, 1994, 343 (8892) :266-268
[9]   THE GSTM1 NULL GENOTYPE AS A POTENTIAL RISK MODIFIER FOR SQUAMOUS-CELL CARCINOMA OF THE LUNG [J].
HIRVONEN, A ;
HUSGAFVELPURSIAINEN, K ;
ANTTILA, S ;
VAINIO, H .
CARCINOGENESIS, 1993, 14 (07) :1479-1481
[10]   INCREASED RISK OF LUNG-CANCER IN JAPANESE SMOKERS WITH CLASS MU GLUTATHIONE-S-TRANSFERASE GENE DEFICIENCY [J].
KIHARA, M ;
KIHARA, M ;
NODA, K ;
OKAMOTO, N .
CANCER LETTERS, 1993, 71 (1-3) :151-155